Cervical infections are a serious disease that usually requires timely and effective drug treatment. Following are the medications for abdominal infections:
I. Anti-infection drugs Since intestinal infections often involve intestinal bacteria, and intestinal genemic bacteria are the main pathogens, drugs that are effective against genemic bacteria are usually selected for initial treatment. For example, third-generation sepsis-like drugs such as twilight and twilight are common options. They have good antibacterial activity against gelatinella, common abdominal infections, e.g., coli, creber. • Anaerobic coverage: taking into account the importance of anaerobics in abdominal infections, nitromazole-type drugs such as or on behalf of nitrazine are important joint drug options. These drugs have a strong microbicide effect on aerobics, such as vulnerable bacterium. In experiential treatments, a combination of head enzymes and nitromics is commonly used to cover a wide range of possible pathogens. • Aligning the use of drugs with the results of the drug: before anti-infection drugs are used, it is desirable to obtain samples such as abdominal fluid, blood, etc. for bacterial development and drug sensitivity testing. Once the results are available, the drugs need to be tailored to the results. In the case of drug-resistant infections, such as those in the abdominal cavity caused by methylenedioxysilin-colluccus (MRSA), the use of drugs such as vancomicin and Linamamine may be required. For gerranes, which produce ultra-species beta-nimamine enzymes (ESBLs), carbon pyroacnectics such as ammonium benzo-histradine and meropenan may be more effective options.
ii. Support for therapeutic drugs • Liquid resuscitation drugs: Patients suffering from abdominal infections may experience dehydration and shock due to inflammation, vomiting and diarrhoea. The use of liquid resuscitation drugs, such as saline water, balancing saline solutions, etc., is required for intravenous infusion. Remedial the patient ‘ s low blood capacity and maintain blood pressure and tissue infusion through rapid rehydration. At the same time, indicators such as vital signs and urine levels of patients should be closely monitored to assess the effects of liquid recovery. • Electrolyte supplements: vomiting and diarrhoea can also lead to electrolyte disorders, often with low potassium, sodium, etc. For low potassium haemorrhagic disease, intravenous dripping or oral potassium supplementation may be performed using potassium chloride solution; for low sodium haemorrhagic disease, the appropriate sodium supplementation method may be chosen depending on the severity of the sodium haemorrhagic disease, such as low sodium sodium sodium sodium sodium sodium chloride capsules which may be orally available, and sodium sodium sodium sodium sodium sodium sodium sodium sodium sodium sodium dichloride solution may be required by intravenous infusion. Maintenance of electrolyte balance helps to maintain normal functioning of vital organs such as the heart, muscle, etc.
• Painkillers: abdominal infections can cause severe abdominal pain, and painkillers can be appropriately used to alleviate the suffering of patients after a clear diagnosis. For mild pain, a non-methodic anti-inflammation drug, such as Broven, can be used, but with regard to its possible irritation in the gastrointestinal tract. For moderate severe pain, opioid analgesics such as morphine, thorphine, etc. may be used, but these drugs have adverse effects such as respiratory inhibition, need to be used with caution and should be used with close observation of the patient ‘ s breathing. • Gastrointestinal powered drugs: abdominal infections can lead to gastrointestinal disorders, symptoms of abdominal swelling, nausea and vomiting. The use of gastrointestinal powered drugs promotes gastrointestinal creeping and reduces these symptoms. For example, Dopanite can contribute to emptiness of the stomach, and Moshapuri can contribute to the creeping of the whole gastrointestinal tract. However, when these drugs are used, care is taken whether the patient has a taboo, such as intestine infarction, to avoid aggravating conditions. Changes in the patient ‘ s symptoms, signs and laboratory results are closely observed during the treatment of medication for abdominal infections. In general, the course of treatment of anti-infection drugs, depending on the severity of the infection and the type of pathogens, usually requires a continuous use of 1-2 weeks or more. At the same time, attention should be paid to the adverse effects of drugs, such as allergies that may result from anti-infective drugs, damage to liver and kidney function, and to timely detection and treatment to ensure the effectiveness and safety of treatment.
